Danaher Corp (NYSE:DHR) has beaten analysts’ expectations for both revenue and earnings in the second quarter by $30 million and $0.03 per share, respectively. Danaher Corporation is a manufacturer of medical, industrial & commercial products.
The company has posted high double digit growth in both earnings and sales in the second quarter on the back of its expansion strategy.
In the second quarter, the company generated a sales growth of 16.5% to $5.8B, compared with the same quarter of last year. Bolt-on and pall acquisitions are the key drivers behind the high double digit growth in sales. Sales from its Life Sciences increased at a mid-single digit, while